Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Frontiers In Neurology , 16 , 1514394
BPC-157 and Cancer Risk Although we see claims saying that BPC157, a peptide, can increase the risk of cancer, there is no scientific evidence suggesting this
Better Skin Health at Home You dont need a clinic visit or an IV drop to experience the same skin-enhancing benefits that celebrities swear by
Association of glucagon-like peptide-1 receptor agonist use with anxiety disorders, depression, self-harm, and suicidality: a large cohort study
What this means if you're considering compounded GLP-1s DiStefano said compounded GLP-1 medications have helped expand access for patients who can't afford brand-name drugs or whose insurance doesn't cover obesity treatment
This reflects the state of play as of early 2026: States that cover GLP-1s for obesity treatment (fee-for-service): Arkansas, Colorado, Connecticut, Delaware, Illinois, Louisiana, Massachusetts, Minnesota, New Mexico, New York, Oregon, Virginia, Washington approximately 13 states total as of January 2026
